Lovegra — Research Summary
Lovegra 100 mg is a sildenafil citrate formulation manufactured by Ajanta Pharma, specifically designed for in-vitro laboratory research examining phosphodiesterase type 5 (PDE5) inhibition mechanisms. This research compound allows investigators to study the pharmacological properties of sildenafil in female-focused formulations, providing valuable insights into vascular biology and nitric oxide signaling pathways. Researchers at Stroid UK Shop utilise this compound to investigate endothelial function, smooth muscle relaxation, and cGMP-dependent cellular mechanisms in controlled laboratory environments.
Laboratory Applications
Investigators examine Lovegra’s sildenafil citrate content to research PDE5 enzyme inhibition pathways and subsequent effects on cyclic guanosine monophosphate (cGMP) levels in cellular models. The compound enables comprehensive analysis of nitric oxide-mediated vasodilation mechanisms, particularly in female reproductive tissue research. Scientists studying erection drugs and sildenafil citrate research applications find this formulation valuable for comparative studies against standard sildenafil preparations. Research protocols often incorporate this compound alongside SARMs investigations to examine potential interactions in multi-compound laboratory studies. Advanced researchers also correlate findings with peptide research to understand comprehensive physiological pathway interactions.
Compound Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Strength | 100 mg per unit |
| Manufacturer | Ajanta Pharma |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Storage Temperature | Room temperature, dry environment |
| Research Applications | PDE5 inhibition, vascular biology |
Research Compliance
Lovegra 100 mg is supplied exclusively for in-vitro research purposes and laboratory analysis. This compound is not intended for human consumption, clinical use, or any therapeutic applications. Researchers must maintain appropriate laboratory protocols, documentation, and safety measures when handling this sildenafil citrate formulation. All investigations should comply with institutional research guidelines and applicable regulations governing pharmaceutical research compounds in laboratory environments.
